BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14657819)

  • 21. Heparin-induced thrombocytopenia--a big deal? It should be!
    Jamani N; Ouwendyk M
    CANNT J; 2000; 10(2):30-5, 39-44; quiz 36-8. PubMed ID: 15712466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
    Matsuo T; Tomaru T; Kario K; Hirokawa T;
    Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Selleng S; Greinacher A
    Semin Thromb Hemost; 2008 Jul; 34(5):425-38. PubMed ID: 18956282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heparin-induced thrombocytopenia].
    Gruel Y; Regina S; Pouplard C
    Rev Prat; 2006 Apr; 56(7):710-8. PubMed ID: 16739902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papaverine prolongs patency of peripheral arterial catheters in neonates.
    Griffin MP; Siadaty MS
    J Pediatr; 2005 Jan; 146(1):62-5. PubMed ID: 15644824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-induced thrombocytopenia.
    Warkentin TE
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients.
    Rabe C; Gramann T; Sons X; Berna M; González-Carmona MA; Klehr HU; Sauerbruch T; Caselmann WH
    Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease.
    Abdelkefi A; Torjman L; Ladeb S; Othman TB; Achour W; Lakhal A; Hsairi M; Kammoun L; Hassen AB; Abdeladhim AB
    J Clin Oncol; 2005 Nov; 23(31):7864-70. PubMed ID: 16258088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial.
    Birch P; Ogden S; Hewson M
    Arch Dis Child Fetal Neonatal Ed; 2010 Jul; 95(4):F252-7. PubMed ID: 20530110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of heparin-induced thrombocytopenia.
    Kouides PA; Fricke W
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):335-45. PubMed ID: 15853606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
    Wester JP; Leyte A; Oudemans-van Straaten HM; Bosman RJ; van der Spoel JI; Haak EA; Porcelijn L; Zandstra DF
    Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparinized saline vs normal saline for maintenance of intravenous access in neonates: an evidence-based practice change.
    Cook L; Bellini S; Cusson RM
    Adv Neonatal Care; 2011 Jun; 11(3):208-15. PubMed ID: 21730915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia: an uncommon but serious complication of heparin use in renal replacement therapy.
    Charif R; Davenport A
    Hemodial Int; 2006 Jul; 10(3):235-40. PubMed ID: 16805883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of heparin-induced thrombocytopenia from heparin-bonded vascular prostheses.
    Mureebe L; Graham JA; Bush RL; Silver D
    Ann Vasc Surg; 2007 Nov; 21(6):719-22. PubMed ID: 17980795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
    Levy JH; Tanaka KA; Hursting MJ
    Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet transfusions in heparin-induced thrombocytopenia: a report of four cases and review of the literature.
    Hopkins CK; Goldfinger D
    Transfusion; 2008 Oct; 48(10):2128-32. PubMed ID: 18657085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2001; (3):CD002772. PubMed ID: 11687025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.
    Shelat SG; Tomaski A; Pollak ES
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):410-4. PubMed ID: 17895512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.